Disorders of aggregation (defects in platelet-platelet interaction) |
Glanzmann thrombasthenia |
deficiency or defect in GP Ilb-IIIa |
|
Disorders of adhesion (defects in platelet-vessel wall interaction) |
Bernard-Soulier syndrome platelet-type von Willebrand disease |
deficiency or defect in GP Ib-IX-V |
|
Disorders of platelet secretion (primary secretion defects) and signal transduction |
defects in platelet-agonist interactions
abnormalities in arachidonic acid
path-ways or thromboxane A2 synthesis
defects in G-protein activation
defects in phosphatidylinositol meta-bolism
defects in protein phosphorylation
defects in calcium mobilization
|
deficiencies of receptors for ADP, collagen, epinephrine or thromboxane A2 impaired liberation of arachidonic acid, cyclooxygenase deficiency or thromboxane synthase deficiency
Gαq deficiency
phospholipase C-β2 deficiency PKC deficiency (Pleckstrin)
|
|
Disorders of platelet secretion and abnormalities of granules |
storage pool diseases (8, a, a8) |
8-granules, α-granules or both |
|
Disorders of procoagulant function |
Scott syndrome |
membrane phospholipid defects |
|
Defects in structural or cytoskeletal components |
MYH9-related disorders
Wiskott-Aldrich syndrome
|
|